TipRanks
Advertisement
Advertisement

GB:APTA Stock Latest News

Aptamer Group Sets Analyst and Investor Meetings for Full-Year Results
Company AnnouncementsAptamer Group Sets Analyst and Investor Meetings for Full-Year Results
4d ago
Aptamer Group Adds Cavendish as Joint Corporate Broker to Bolster Investor Reach
PremiumCompany Announcements
Aptamer Group Adds Cavendish as Joint Corporate Broker to Bolster Investor Reach
2M ago
Aptamer Group boosts director stakes and launches major incentive scheme
PremiumCompany Announcements
Aptamer Group boosts director stakes and launches major incentive scheme
2M ago
Aptamer Group lifts revenue and pipeline as high-margin licensing takes hold
PremiumCompany Announcements
Aptamer Group lifts revenue and pipeline as high-margin licensing takes hold
3M ago
Aptamer Group moves to plug Ebola testing gap with Bundibugyo diagnostic push
PremiumCompany Announcements
Aptamer Group moves to plug Ebola testing gap with Bundibugyo diagnostic push
3M ago
Aptamer Group advances AI-driven discovery, automation and therapeutic pipeline after fundraise
PremiumCompany AnnouncementsAptamer Group advances AI-driven discovery, automation and therapeutic pipeline after fundraise
4M ago
Aptamer partners with Imperial College on Gates-backed folic acid test
Premium
Company Announcements
Aptamer partners with Imperial College on Gates-backed folic acid test
4M ago
Aptamer Group Wins Shareholder Backing for £4.55m Fundraise
Premium
Company Announcements
Aptamer Group Wins Shareholder Backing for £4.55m Fundraise
6M ago
Aptamer Group Raises £4.5m in Funding Round Ahead of Key Shareholder Vote
PremiumCompany Announcements
Aptamer Group Raises £4.5m in Funding Round Ahead of Key Shareholder Vote
6M ago
Aptamer Group opens £0.5m retail offer alongside £4.3m placing
PremiumCompany Announcements
Aptamer Group opens £0.5m retail offer alongside £4.3m placing
7M ago
Aptamer Group Raises £4.3m to Accelerate AI and Radiopharmaceutical Growth Plans
PremiumCompany Announcements
Aptamer Group Raises £4.3m to Accelerate AI and Radiopharmaceutical Growth Plans
7M ago
Aptamer Group lifts revenues and extends cash runway as Optimer deals scale up
PremiumCompany Announcements
Aptamer Group lifts revenues and extends cash runway as Optimer deals scale up
7M ago
Aptamer Group launches £3.75m equity raise to fund AI-enabled discovery and pipeline expansion
PremiumCompany AnnouncementsAptamer Group launches £3.75m equity raise to fund AI-enabled discovery and pipeline expansion
7M ago
Aptamer Group launches Optimer radiopharmaceutical push with Radiopharmium
Premium
Company Announcements
Aptamer Group launches Optimer radiopharmaceutical push with Radiopharmium
7M ago
Aptamer Group Updates Status of EMI Share Option Block Listing
Premium
Company Announcements
Aptamer Group Updates Status of EMI Share Option Block Listing
7M ago
Aptamer Group hits key milestone in Metir pathogen detector collaboration
PremiumCompany Announcements
Aptamer Group hits key milestone in Metir pathogen detector collaboration
8M ago
Aptamer’s Optimer Tech Powers Twist Bioscience’s New TrueAmp NGS Library Prep Kit
PremiumCompany Announcements
Aptamer’s Optimer Tech Powers Twist Bioscience’s New TrueAmp NGS Library Prep Kit
8M ago
Aptamer Group Secures New Pharma Contracts and First Cash from Optimer Licensing
PremiumCompany Announcements
Aptamer Group Secures New Pharma Contracts and First Cash from Optimer Licensing
8M ago
Aptamer Group Reasserts Cash Runway to June 2027 Amid Media Speculation
PremiumCompany Announcements
Aptamer Group Reasserts Cash Runway to June 2027 Amid Media Speculation
9M ago
Aptamer Group lifts H1 revenue 27% as licensing push builds recurring income
PremiumCompany AnnouncementsAptamer Group lifts H1 revenue 27% as licensing push builds recurring income
9M ago
Aptamer Group Secures Second Enzyme-Modulation Licence with Alphazyme for Hot-Start PCR Optimer
Premium
Company Announcements
Aptamer Group Secures Second Enzyme-Modulation Licence with Alphazyme for Hot-Start PCR Optimer
10M ago
Aptamer Group Partners with Twist Bioscience for NGS Market Expansion
Premium
Company Announcements
Aptamer Group Partners with Twist Bioscience for NGS Market Expansion
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >